The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $3.42 in the last session, down -1.72% from day before closing price of $3.48. In other words, the price has decreased by -$1.72 from its previous closing price. On the day, 1.94 million shares were traded. RCKT stock price reached its highest trading level at $3.52 during the session, while it also had its lowest trading level at $3.36.
Ratios:
We take a closer look at RCKT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.30 and its Current Ratio is at 7.30. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On August 20, 2025, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $10.
BofA Securities Downgraded its Buy to Neutral on July 25, 2025, while the target price for the stock was maintained at $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’25 when Schwartz Jonathan David sold 2,545 shares for $2.98 per share. The transaction valued at 7,592 led to the insider holds 299,064 shares of the business.
Shah Gaurav sold 6,276 shares of RCKT for $18,721 on Nov 18 ’25. The CEO now owns 778,296 shares after completing the transaction at $2.98 per share. On Nov 18 ’25, another insider, Militello John, who serves as the insider of the company, sold 1,086 shares for $2.98 each. As a result, the insider received 3,240 and left with 65,920 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 370120000 and an Enterprise Value of 172407024.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.47, which has changed by -0.7264151 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $13.35, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 0.83%, while the 200-Day Moving Average is calculated to be -16.62%.
Shares Statistics:
According to the various share statistics, RCKT traded on average about 2.34M shares per day over the past 3-months and 1683220 shares per day over the past 10 days. A total of 108.21M shares are outstanding, with a floating share count of 99.61M. Insiders hold about 7.95% of the company’s shares, while institutions hold 86.15% stake in the company. Shares short for RCKT as of 1765756800 were 11908746 with a Short Ratio of 5.09, compared to 1763078400 on 11555436. Therefore, it implies a Short% of Shares Outstanding of 11908746 and a Short% of Float of 21.370001.
Earnings Estimates
Currently, 13.0 analysts are dedicated to thoroughly evaluating and rating the performance of Rocket Pharmaceuticals Inc (RCKT) in the stock market.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.37 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.66 and -$2.19 for the fiscal current year, implying an average EPS of -$2.02. EPS for the following year is -$1.29, with 12.0 analysts recommending between $0.69 and -$1.83.
